Obesity and liver disease are two of the fastest-growing health challenges worldwide. While GLP-1 drugs like semaglutide (Ozempic®, Wegovy®) have changed the landscape of weight-management, researchers are now looking for next-generation therapies that go beyond appetite suppression. One of the most promising is Survodutide (BI 456906), a peptide currently in late-stage clinical trials. Survodutide is a […]
Healthy blood vessels are the foundation of long-term cardiovascular health, brain function, and overall vitality. As we age, however, vascular tissues lose elasticity, circulation declines, and the risk of heart disease, stroke, and cognitive impairment increases. While lifestyle, exercise, and nutrition play central roles, researchers have also explored short peptides known as bioregulators to support tissue […]
Fat metabolism and body composition have always been at the center of performance and health research. While stimulants and appetite suppressants dominate the fat-loss category, peptides like SLU-PP (Selective Lipid Uptake Peptide) are beginning to shift the conversation. Instead of relying on heart-rate elevation or calorie restriction, SLU-PP is being studied for its ability to optimize […]
Sleep is one of the most important pillars of recovery, performance, and overall health. While many supplements aim to improve rest — from melatonin to magnesium — very few target the neurochemical pathways of sleep directly. That’s where DSIP (Delta Sleep-Inducing Peptide) comes in. Originally discovered in the 1970s, DSIP is a neuropeptide linked to the […]
Obesity and metabolic disease continue to be some of the most pressing health challenges worldwide. While diet, exercise, and lifestyle remain the foundation of weight management, many people turn to medical therapies for added support. Over the past decade, GLP-1 agonists like semaglutide (Ozempic®, Wegovy®) have dominated the conversation — but they aren’t the only peptides […]